Yearly Archives: 2024

Department of Health and Social Care (DHSC) has issued a medicine supply notification for: Norethisterone (Noriday®) 350microgram tablets. MSN/2024/009 Tier 2 – medium impact Date of issue: 25th January 2024 Norethisterone (Noriday®) 350microgram tablets are out of stock until mid-February 2024. Alternative progestogen-only oral contraceptives remain available and can support increased demand. A copy of [...]

The post Medicine Supply Notification: Norethisterone (Noriday® ) 350microgram tablets appeared first on Community Pharmacy England.

Daily Mail Given the current concerns around the spread of measles, NHS England has launched a catch-up campaign for missed MMR vaccines. It has been suggested by some – including Health Select Committee Chair Steve Brine MP – that the Government should make more use of pharmacy to deliver public health vaccinations such as this. We [...]

The post Potential role for pharmacy in delivering MMR jabs appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for: Lantus® Solostar® (insulin glargine) 100units/ml solution for injection 3ml pre-filled pens. MSN/2024/008 Tier 2 – medium impact Date of issue: 23rd January 2024 Lantus® (insulin glargine) Solostar® 100units/ml solution for injection 3ml pre-filled pens will be in limited supply from the [...]

The post Medicine Supply Notification: Lantus® Solostar® (insulin glargine) 100units/ml solution for injection 3ml pre-filled pens appeared first on Community Pharmacy England.

Pharmacy press Pharmacy owners preparing for the Pharmacy First service have raised concerns around workload, funding and other issues. We have issued the following comment about the sector’s readiness to take on the service. Fin McCaul, an independent community pharmacy owner, Community Pharmacy England Regional Representative for the North West, Negotiating Team Member and Chair [...]

The post Concerns about Pharmacy First implementation appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 6 January 2024) has been published and includes articles on: Valproate (Belvo, Convulex, Depakote, Dyzantil, Epilim, Epilim Chrono or Chronosphere, Episenta, Epival, and Syonell▼): new safety and educational materials to support regulatory  measures in men and women under 55 years [...]

The post MHRA Drug Safety Update: January 2024 appeared first on Community Pharmacy England.